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Abstract 
Background: The intestinal carriage of nontuberculous mycobacteria (NTM) is associated with disease, especially in 
severely immunocompromised individuals. These organisms, although often considered contaminants, have been 
known to cause various types of illnesses. We aimed to determine the prevalence of and associated factors for NTM 
among patients booked for colonoscopy at the University Teaching Hospital (UTH) in Lusaka.
Methods: We randomly recruited 97 patients attending routine endoscopy procedures between November 2012 
and October 2013 and after consent, administered a structured questionnaire. We collected stool and intestinal lavage 
samples, as well as biopsy samples from the descending colon and the caecal area during the endoscopy procedure. 
Samples were cultured using the mycobacteria growth indicator tube (MGIT) method followed by the GenoType 
Mycobacterium CM/AS assay for identification of NTM. Results were expressed as means and standard deviations; 
proportions were expressed as percentages with corresponding 95% confidence intervals. We used Fisher’s exact Chi 
square test for cross-tabulations where appropriate. All statistical tests were two-sided, with a significance level set at 
p < 0.05.
Results: Out of the 97 patients, 45 (46.4%) were female and 52 (53.6%) were males with mean ages 49.1 (±16.7, 
range 24–85) and 44.4 (±15.0, range 18–80) years respectively. The prevalence of NTM was 7.2% (95% CI 1.9–12.4), 
while that of Mycobacterium tuberculosis (MTB) was 6.2% (95% CI 2.3–13.0). Carriage of NTM was not significantly 
associated with age, sex or presenting symptoms such as diarrhoea, abdominal pain, weight loss as well as HIV status. 
There were no identifiable predictors of NTM carriage.
Conclusion: The results have shown that NTM and MTB are present in the intestines of the patients booked for 
colonoscopy at the University Teaching Hospital in Lusaka, but their presence is not related to presenting symptoms. 
Given that this may be an indicator of a bigger burden of NTM in this population, there is a need to explore this 
burden and the contribution it could have on abdominal disease in general as well as examine potential factors that 
might be important predictors.
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Background
The intestinal carriage of nontuberculous mycobacteria 
(NTM) is associated with disease in both immunocom-
petent as well as immunocompromised individuals [1]. 
Nontuberculous mycobacteria (NTM) are a group of 
Mycobacterium species different from those belonging to 
the Mycobacterium tuberculosis complex (MTB) and M. 
leprae. There are currently over 150 NTM species recog-
nised [2]. The organisms, although frequently dismissed 
as mere contaminants, have been known to cause vari-
ous types of illnesses affecting the skin, lungs, intestines, 
the joints as well as the blood stream. There has been an 
increased incidence of NTM since the advent of HIV, 
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partly due to HIV but also because of increased aware-
ness [3–5].
Many NTM are free-living organisms which have been 
isolated in a wide range of environments, including water, 
soil, dust and aerosols. In general, disease due to NTM 
is more common in individuals with suppressed local 
or systemic immunity than those with normal immu-
nity. However, some studies have found an increased 
incidence of NTM disease in the elderly [6]. Some of 
the conditions predisposing to systemic, respiratory and 
abdominal NTM disease include HIV, emphysema, pneu-
moconiosis, cystic fibrosis, previous gastrectomy, contin-
uous ambulatory dialysis and chronic alcoholism [7–9]. 
In the gastrointestinal tract, both M. tuberculosis and 
NTM can cause abdominal pain, ascites, chronic diar-
rhoea and other clinical manifestations [10].
Gastrointestinal (GI) disease is characterised by inva-
sion of Peyer’s patches and mesenteric lymph nodes 
of the small intestine, leading to foamy histiocytes and 
mycobacteria-laden macrophages within the lamina 
propria of the intestinal mucosa. Symptoms include dif-
fuse abdominal pain, weight loss, fever and/or diarrhoea. 
Findings on endoscopy include multiple raised nod-
ules or normal-appearing mucosa. Other findings may 
include ulceration, erythema, oedema, friability, reduced 
mucosal vascularity, stricture, and aphthous erosions [11, 
12]. The prevalence of NTM in intestinal specimens such 
as stool, intestinal lavage and colon biopsies is unknown.
Little is known about the role of NTM in the aetiol-
ogy of abdominal disease in Zambian patients. Further 
it has been suggested that the burden of nontuberculous 
mycobacteria in Zambia, some of which may present 
with abdominal symptoms, may be underestimated [13]. 
This article presents the results of a descriptive study of 
carriage rates of NTM as well as factors associated with 
their carriage in patients booked for endoscopy at the 
University Teaching Hospital (UTH) in Lusaka, Zambia.
Methods
Design and study population
We randomly sampled patients booked for endoscopy 
at the University Teaching Hospital in Lusaka between 
November 2012 and October 2013 in this cross-sectional 
survey. All patients who were 18  years and older who 
were booked for either colonoscopy or flexible sigmoi-
doscopy were eligible to take part in the study. Patients 
who were on treatment for TB, those who were found to 
have cancer lesions on endoscopy or those with debilitat-
ing conditions were not considered for recruitment.
Sample collection and processing
Consenting patients were asked to answer questions on 
their demographic characteristics, symptoms and drug 
history using a structured questionnaire, which took up 
to 10  min. Blood was collected for HIV and haemoglo-
bin tests. HIV testing was done using the recommended 
national testing algorithm in Zambia, which follows the 
standard two test algorithm that starts with the Allere 
Determine® HIV1/2 test kit (Abbott, Japan) followed by 
the Uni-Gold™  Recombigen HIV-1/2 (Trinity Biotech) 
if positive [14]. The two tests showed an agreement of 
100%. Furthermore, patients who wanted to know their 
results were offered counselling services before the 
results were shared with them.
Samples of stool and intestinal lavage were collected 
from the patients before they underwent their sched-
uled procedure. After specimen collection, the patients 
underwent either a flexible sigmoidoscopy or a colonos-
copy, during which descending colon biopsy and/or cae-
cal biopsy samples were obtained from eligible patients. 
The biopsy samples were collected in 2 ml cryovials filled 
with saline. These samples were then used to test for the 
presence of mycobacteria as described below.
The BACTEC mycobacteria growth indicator tubes 
(MGIT) liquid culture method was used to establish 
the presence of nontuberculous mycobacteria from the 
biopsies and lavage fluids after decontamination with 
6% NaOH. The biopsy samples were first homogenised 
before being transferred to 50 ml Falcon centrifuge tubes 
for processing, in much the same way as sputum samples 
are processed. For each batch of samples processed, care 
was taken to ensure that a positive (H37Rv laboratory 
stock) and a negative control (phosphate buffer, pH 6.8) 
were included. The samples were incubated in the MGIT 
960 machine at 37  °C for up to 42  days. No additional 
supplements for isolation of fastidious mycobacteria 
were used. Samples from positive MGIT tubes were inoc-
ulated onto blood agar plates to check for contamination, 
followed by Ziehl Neelsen (ZN) staining and the Capilia 
assay (Capilia® TB, TAUNS Laboratories Inc, Shizuoka, 
Japan) to confirm M. tuberculosis [15, 16]. For identifi-
cation, we used the GenoType mycobacterium CM/AS 
(Hain Lifescience, GmbH, Germany) assay according to 
manufacturer’s specifications.
DNA extraction
To extract DNA, 1 ml was drawn from a positive MGIT 
tube into a container and centrifuged at 10,000g for 
15 min in a class II safety cabinet. The supernatant was 
discarded and the pellet was re-suspended in 300  µl 
of molecular grade water. Following that, the suspen-
sion was sonicated for 15  min, followed by incubation 
in a water bath for 20 min at 95 °C as per manufacturer 
instructions [17].
In order to test for contamination of water sources 
with NTM, we collected water samples in 50 ml Falcon 
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tubes at different time-points in the endoscopy unit 
(where the sigmoidoscopy and colonoscopies took 
place) as well as in the TB laboratory. These samples 
were centrifuged at 3000  rpm for 15  min, supernatant 
discarded and 5 ml of the remaining fluid was processed 
for mycobacteria using the MGIT method as described 
above.
Statistical analysis
A structured questionnaire was designed to collect 
demographic characteristics, symptoms and drug his-
tory. The data was entered into a questionnaire created 
in Epidata statistical software on a panel that matched 
the unique identifier for the individual’s demographic 
data, then analysed using STATA (Version 11.2, Stata-
Corp, College Station, Texas). Sample descriptions 
were expressed as means with their respective stand-
ard deviations; whereas proportions (e.g. prevalence) 
were expressed as percentages with corresponding 
95% confidence intervals. We used Fisher’s exact Chi 
square test for cross-tabulations where appropriate. 
Tests for normality of age and other continuous vari-
ables were done using the Shapiro–Wilks test. Man-
tel–Haenszel tests were used to test for interaction 
and confounding. Multivariable logistic regression was 
used to look for predictors for carriage of mycobacte-
ria. A p < 0.05 was considered statistically significant. 
The model comprised age, occupation, residence, level 
of education as well as presenting symptoms such as 
abdominal pain, diarrhoea, vomiting, fever and weight 
loss. The Akaike (AIC) and Bayesian (BIC) information 
criteria were used for model diagnostics. The outcome 
variable was carriage of any nontuberculous mycobac-
teria. Carriage of MTB was the secondary outcome 
variable.
Ethical considerations
All the respondents provided written informed consent 
before participating in the study. Although unlinked HIV 
testing was done, patients who wanted to know their 
results were made to undergo counselling according to 
standard national guidelines before results were shared 
with them. The proposal was approved by the University 




Out of 97 participants recruited, 45 (46.4%) were female 
and 52 (53.6%) were male, with mean age 46.6  years 
(±15.9). The age distribution by sex was similar in both 
females and males (mean 49.1 ± 16.7 vs 44.4 ± 14.9 years, 
p = 0.15) respectively. The refusal rate was 4%.
Medical characteristics
Abdominal pain (60.8%, 95% CI 50.4–70.6) was the most 
common indication for colonoscopy, followed by passing 
blood in stool (39.2%, 95% CI 29.4–49.6), and diarrhoea 
(23.7%, 95% CI 15.6–33.4) as shown in Table 1. The mean 
haemoglobin was 11.9  g/dl (±3.0), whereas the overall 
HIV status was 19.3% (95% CI 10.5–26.6). There were 
no significant differences between males and females 
in terms of presenting symptoms, HIV status and mean 
haemoglobin levels.
Carriage rates and diagnostic yield
Mycobacteria species were isolated in 13 participants 
(13.4%, 95% CI 6.5–20.3) out of which NTM were iso-
lated in 7 (7.2%, 95% CI 1.9–12.4) of the participants. M. 
tuberculosis was isolated in 6.2% (95% CI 2.3–13.0) of the 
participants. There were no differences in carriage rates 
between males and females. Descending colon samples 
were the most likely to be positive (9.8%, 95% CI 3.7, 
15.8) followed by stool samples (6.8%, 95% CI 1.0–12.6), 
caecal biopsy (6.1%, 95% CI 0.3–11.8) and intestinal lav-
age samples (5.9%, 95% CI 0.3–11.5) as shown in Table 2. 
The contamination rate was 17.6%.
No participant carried more than one species of myco-
bacteria at a time. However, in 3/69 participants (4.3%) 
we isolated mycobacteria in both stool and descending 
colon biopsy. Three other patients (4.3%) also produced 
mycobacterium isolates from both caecal biopsies and 
descending biopsy specimens.
The intestinal carriage of mycobacteria was not asso-
ciated with age, sex or presenting symptoms such as 
diarrhoea, abdominal pain, weight loss, rectal bleeding, 
anaemia as well as HIV status. This is shown in Table 3.
Discussion
In this study, we found evidence of NTM among patients 
booked for colonoscopy and flexible sigmoidoscopy at 
UTH. This observed prevalence is higher than a previ-
ous report in the stools of patients with chronic diar-
rhoea [18] in the same hospital. The reasons for this are 
unclear and were beyond the scope of this study, but the 
development of MGIT detection systems in the inter-
val between these studies may partly explain the higher 
apparent prevalence. However, much higher prevalences 
have been detected from other Zambian patient popu-
lations using sputum samples, where the prevalence of 
NTM was as high as 56% [13, 19]. Given the known bio-
logical characteristics of these micro-organisms, their 
presence in this population also suggests an environmen-
tal contamination.
This being a hospital based study, there are inher-
ent external validity reservations for such findings, as 
this study was limited to a highly selected population 
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scheduled for endoscopy. There may be arguments sup-
porting the thinking that external validity can only be 
guaranteed if such a study should have been done in the 
general population in Lusaka. We argue that the great 
majority of our participants were generally healthy, 
apart from having abdominal symptoms for which they 
sought endoscopy services. It would not be possible to 
justify colonoscopy in unselected patients in the gen-
eral population, merely for the purpose of obtaining 
biopsies. Notwithstanding these limitations, we think 
that these findings may even be an under-estimate of 
the burden of NTM. This is due to the use of the cul-
ture methods without special incubation temperatures 
or additional nutritional supplements to culture more 
fastidious NTM [20] from both the clinical and water 
samples. Further, the use of N-acetyl l-cysteine—6% 
NaOH (NALC–NAOH) for decontamination may have 
been overly harsh for some samples with low levels of 
organisms [21]. Our results were not affected by non-
participation due to refusal to give consent as this 
remained below 5%. We consider it likely that this pop-
ulation has a measurable carriage rate of NTM in the 
intestine.
Finding that the carriage of NTM was not associated 
with the gender of the respondent, age, employment sta-
tus, or presenting symptoms was not surprising given 
the ubiquitous nature of these organisms. These results 
illustrate the abundant nature of NTM, which are found 
in soil, dust and water systems [22]. This might explain 
the general exposure that exists irrespective of the age, 
sex and other patient characteristics. However, previous 
studies elsewhere have shown a relationship between iso-
lation of NTM and both gender and age of the patient [6, 
23] and type of occupation [24]. Tests for NTM done on 
the hospital water systems during the period of the study 
were found to be negative. Given that the water sam-
ples and the clinical samples were processed in the same 
way, our findings suggest that the NTM were not due to 
contamination.
It has been suggested that NTM, such as the Myco-
bacterium avium complex, may be responsible for 
some non-specific abdominal symptoms such as ano-
rexia, weight loss, dysphagia, odynophagia and abdom-
inal pain [11]. While abdominal pain was the most 
common presenting symptom in our patients (72.0%), 
there was no relationship between the carriage of 
NTM and presenting symptoms such as abdominal 
pain, weight loss, vomiting, nausea, dizziness and ano-
rexia. We did not isolate Mycobacterium avium species 
in our patients.
Table 1 Demographic characteristics and  presenting 
symptoms of study participants, stratified by gender
a Except for the age, where a t test was used, the p value was derived with the 






Gender [n (%)] 97 45 (46.4) 52 (53.6) 0.54
Age in years [Mean 
(SD)]
46.6 (15.9) 49.1 (16.7) 44.4 (14.9) 0.15
Area of residence 
[n (%)]
0.22
 Low cost 49 (50.5) 22 (48.9) 27 (51.9)
 Medium cost 27 (27.8) 10 (22.2) 17 (32.7)
 High cost 21 (21.7) 13 (28.9) 8 (15.4)
Occupation status 0.01
 Unemployed 52 (53.6) 31 (68.9) 21 (40.4)
 Employed 45 (46.4) 14 (31.1) 31 (59.6)
Presenting symptoms
 Abdominal pain 0.88
  Yes 59 (60.8) 27 (60.0) 32 (61.5)
  No 23 (39.2) 18 (40.0) 20 (38.5)
 Blood in stool 0.50
  Yes 38 (39.2) 16 (35.6) 22 (42.3)
  No 59 (60.8) 29 (64.4) 30 (57.7)
 Diarrhoea 0.80
  Yes 23 (23.7) 10 (22.2) 13 (25.0)
  No 74 (76.3) 35 (77.8) 39 (75.0)
 Vomiting 0.39
  Yes 16 (16.5) 9 (20.0) 7 (13.5)
  No 81 (83.5) 36 (80.0) 45 (86.5)
 Weight loss 0.08
  Yes 18 (18.6) 5 (11.1) 13 (25.0)
  No 79 (81.4) 40 (88.9) 39 (75.0)
 Fever 0.72
  Yes 8 (8.2) 3 (6.7) 5 (9.6)
  No 87 (91.8) 42 (93.3) 47 (90.4)
 HIV 0.95
  Yes 17 (19.3) 8 (19.1) 9 (19.6)
  No 71 (80.7) 34 (80.9) 37 (80.4)
 Anaemia 0.98
  Yes 44 (51.2) 20 (51.3) 24 (51.1)
  No 42 (48.8) 19 (48.7) 23 (48.9)
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We found a higher diagnostic yield of NTM from 
colonic biopsies compared to stool and lavage samples, 
although this was not statistically significant. Mycobacte-
rium avium is known to be the most frequently isolated 
NTM from the gastrointestinal tract among immuno-
compromised patients [25]. However, this was not the 
case in this study because Mycobacterium gordonae was 
the most frequently isolated species in our patients, fol-
lowed by M. Kansasii and M. genavense. All the isolated 
species were potentially pathogenic [26]. Reports of 
increasing incidence of nontuberculous mycobacteria 
point to the need for further attention to these organisms 
[3, 27].
It is well known that immune-compromised patients 
are more likely to suffer from disease caused by NTM 
than the general population. Carriage rates of NTM were 
not associated with levels of haemoglobin and HIV status 
in our patients. The HIV prevalence was 19.3%, and the 
patients were generally healthy with very few who were 
chronically ill or had other debilitating illnesses. Com-
pared to the general Zambian adult population, whose 
HIV prevalence according to the Zambia Demographic 
and Health Survey (ZDHS) [28] was 13.3% in 2014, the 
HIV prevalence in our population was higher.
Some of our patients had M. tuberculosis isolates. How-
ever, only one patient (who was not suspected to have TB 
at the time) showed endoscopic findings that were con-
sistent with abdominal tuberculosis in the ileo-caecal 
area. Culture of the caecal biopsy was positive for M. 
tuberculosis and he was subsequently treated for abdomi-
nal TB. Other patients were referred to the appropriate 
TB services for further evaluation.
Conclusion
Our results have demonstrated presence of NTM in this 
population, suggesting an environmental contamina-
tion of the gut by potentially pathogenic nontuberculous 
mycobacteria that was not associated with any symptoms 
or demographic status. The extent to which these organ-
isms are responsible for some of the morbidity in our 
patients remains to be unravelled. Given that this may be 
an indicator or a bigger burden of NTM in this popula-
tion, there is thus need to further explore this burden and 
the contribution it could have on the disease in the intes-
tine as well as critically examining potential factors that 
might be important predictors. We found that descend-
ing colon biopsies gave the highest yield for detection of 
NTM.
Table 2 Diagnostic yield for Mycobacterial spp. from abdominal specimens among endoscopy patients attending endos-
copy clinic at University Teaching Hospital in Zambia
Sample size for the participants was n = 97
Sampling was random among consenting respondents
Specimen Total number isolated (%) Species isolated Diagnostic yield (%)










































































































































































































































































































































































































































































































































































Page 7 of 7Chongwe et al. BMC Res Notes  (2017) 10:27 
Abbreviations
HIV: human immunodeficiency virus; MGIT: mycobacteria growth indicator 
tube; NTM: nontuberculous mycobacteria; UTH: University Teaching Hospital.
Authors’ contributions
GC and PK took part in the planning of the study, data collection, analysis 
and writing of the manuscript. CM took part in the planning of the study, 
analysis and writing of the manuscript. All authors read and approved the final 
manuscript.
Author details
1 Department of Public Health, School of Medicine, University of Zambia, 
Box 50110, Lusaka, Zambia. 2 Tropical Gastroenterology Unit, School of Medi-
cine, Department of Internal Medicine, University of Zambia, Box 50110, 
Lusaka, Zambia. 3 Barts and The London School of Medicine and Dentistry, 
London, UK. 
Acknowledgements
The authors would like to express their gratitude to the following individuals 
for the invaluable support rendered during the conduction of the survey and 
report writing: Ms Rose Soko, Mr Themba Banda, Mr Patrick Kaonga, Ms Ellen 
Besa, Dr. Jean-Baptiste Nzayisenga, Dr. Edford Sinkala and Dr. Violet Kayamba.
Competing interests
The authors declare that they have no competing interests.
Availability of data and materials
The datasets analyzed during the current study are available from the cor-
responding author on reasonable request.
Consent statement
The study was approved by the University of Zambia Biomedical Research 
Ethics Committee. Written informed consent was obtained from all patients 
who took part in the study.
Funding
Financial support for this study was provided by the Research Support Centre 
at the University of Zambia School of Medicine (UNZA-SOM), through the 
Southern African Consortium for Research Excellence (SACORE), which is part 
of the African Institutions Initiative Grant of the Wellcome Trust (Company 
Number 2711000), a charity (No. 210183) registered in England. Neither Well-
come Trust nor SACORE had a role in the design, conduct and interpretation 
of the study.
Received: 28 September 2015   Accepted: 9 December 2016
References
 1. Faria S, Joao I, Jordao L. General overview on nontuberculous myco-
bacteria, biofilms, and human infection. J Pathog. 2015;2015:809014. 
doi:10.1155/2015/809014.
 2. Euzeby J. List of prokaryotic names with standing in nomenclature-
genus. In: Proteus. 2013. http://www.bacterio.net/mycobacterium.html. 
Accessed 5 Dec 2016.
 3. Henry M, Inamdar L, O’Riordain D, Schweiger M, Watson J. Nontubercu-
lous mycobacteria in non-HIV patients: epidemiology, treatment and 
response. Eur Res J. 2004;23:741–6. doi:10.1183/09031936.04.00114004.
 4. Chan ED, Iseman MD. Underlying host risk factors for nontuberculous 
mycobacterial lung disease. Semin Respir Crit Care Med. 2013;34(1):110–
23. doi:10.1055/s-0033-1333573.
 5. Halstrom S, Price P, Thomson R. Review: environmental mycobacteria 
as a cause of human infection. Int J Mycobacteriol. 2015;4(2):81–91. 
doi:10.1016/j.ijmyco.2015.03.002.
 6. Mirsaeidi M, Farshidpour M, Ebrahimi G, Aliberti S, Falkinham JO. Manage-
ment of nontuberculous mycobacterial infection in the elderly. Eur J 
Intern Med. 2014;25(4):356–63.
 7. Falkinham JO. Epidemiology of infection by nontuberculous mycobacte-
ria. Clin Microbiol Rev. 1996;9(2):177–215.
 8. Katoch VM. Infections due to non-tuberculous mycobacteria. Indian J 
Med Res. 2004;120:290–304.
 9. Ding LW, Lai CC, Lee LN, Hsueh PR. Abdominal nontuberculous mycobac-
terial infection in a university hospital in Taiwan from 1997 to 2003. J For-
mos Med Assoc. 2006;105(5):370–6. doi:10.1016/s0929-6646(09)60132-7.
 10. Debi U, Ravisankar V, Prasad KK, Sinha SK, Sharma AK. Abdominal 
tuberculosis of the gastrointestinal tract: revisited. World J Gastroenterol. 
2014;20(40):14831–40. doi:10.3748/wjg.v20.i40.14831.
 11. Bhaijee F, Subramony C, Tang SJ, Pepper DJ. Human immunodeficiency 
virus-associated gastrointestinal disease: common endoscopic biopsy 
diagnoses. Pathol Res Int. 2011;2011:247923. doi:10.4061/2011/247923.
 12. Huh JG, Kim YS, Lee JS, Jeong TY, Ryu SH, Lee JH, et al. Mycobacterium 
ulcerans infection as a cause of chronic diarrhoea in an AIDS patient: a 
case report. World J Gastroenterol. 2008;14(5):808–11.
 13. Buijtels PC, van der Sande MA, Parkinson S, Verbrugh HA, Petit PL, van 
Soolingen D. Isolation of non-tuberculous mycobacteria at three rural 
settings in Zambia; a pilot study. Clin Microbiol Infect. 2010;16(8):1142–8. 
doi:10.1111/j.1469-0691.2009.03072.x.
 14. Ministry of Health [Zambia]. Adult and adolescent antiretroviral therapy 
protocols. Lusaka: Government of the Republic of Zambia; 2010.
 15. Global Laboratory Initiative. Mycobacteriology laboratory manual. 
Geneva: WHO Stop TB Partnership; 2014.
 16. Muchwa C, Akol J, Etwom A, Morgan K, Orikiriza P, Mumbowa F, et al. 
Evaluation of Capilia TB assay for rapid identification of Mycobacterium 
tuberculosis complex in BACTEC MGIT 960 and BACTEC 9120 blood 
cultures. BMC Res Notes. 2012;5:44. doi:10.1186/1756-0500-5-44.
 17. Hain Lifescience GmbH. GenoType mycobacteria CM. Nehren: Hain 
Lifescience; 2011. p. 2.
 18. Kelly P, Baboo KS, Wolff M, Ngwenya B, Luo N, Farthing MJ. The prevalence 
and aetiology of persistent diarrhoea in adults in urban Zambia. Acta 
Trop. 1996;61(3):183–90.
 19. Buijtels PC, van-der Sande MA, de Graaff CS, Parkinson S, Verbrugh HA, 
Petit PL, et al. Nontuberculous mycobacteria, Zambia. Emerg Infect Dis. 
2009;15(2):242–9.
 20. Hillemann D, Richter E, Rüsch-Gerdes S. Use of the BACTEC mycobacteria 
growth indicator tube 960 automated system for recovery of mycobacte-
ria from 9558 extrapulmonary specimens, including urine samples. J Clin 
Microbiol. 2006;44(11):4014–7. doi:10.1128/JCM.00829-06.
 21. Ferroni A, Vu-Thien H, Lanotte P, Le Bourgeois M, Sermet-Gaudelus I, 
Fauroux B, et al. Value of the chlorhexidine decontamination method 
for recovery of nontuberculous mycobacteria from sputum samples 
of patients with cystic fibrosis. J Clin Microbiol. 2006;44(6):2237–9. 
doi:10.1128/JCM.00285-06.
 22. Falkinham JO. Nontuberculous mycobacteria in the environment. Clin 
Chest Med. 2002;23(3):529–51.
 23. Bodle EE, Cunningham JA, Della-Latta P, Schluger NW, Saiman L. 
Epidemiology of nontuberculous mycobacteria in patients without HIV 
infection, New York City. Emerg Infect Dis. 2008;14(3):390–6. doi:10.3201/
eid1403.061143.
 24. Falkinham JO. The changing pattern of nontuberculous mycobacterial 
disease. Can J Infect Dis. 2003;14(5):281–6.
 25. Huh J-G, Kim Y-S, Lee J-S, Jeong T-Y, Ryu S-H, Lee J-H, et al. Mycobacterium 
ulcerans infection as a cause of chronic diarrhea in an AIDS patient: a case 
report. World J Gastroenterol. 2008;14(5):808–11. doi:10.3748/wjg.14.808.
 26. Jarzembowski JA, Young MB. Nontuberculous mycobacte-
rial infections. Arch Pathol Lab Med. 2008;132(8):1333–41. 
doi:10.1043/1543-2165(2008)132[1333:nmi]2.0.co;2.
 27. Pedro HSP, Pereira MIF, Goloni MRA, Pires FC, Oliveira RS, da Rocha MAB, 
et al. Mycobacterium tuberculosis in a HIV-1-infected population from 
Southeastern Brazil in the HAART era. Trop Med Int Health. 2011;16(1):67–
73. doi:10.1111/j.1365-3156.2010.02681.x.
 28. Central Statistical Office (CSO) [Zambia], Ministry of Health (MOH) 
[Zambia], and ICF International. Zambia Demographic and Health Survey 
2013–2014. Rockville: Central Statistical Office, Ministry of Health, ICF 
International; 2014.
